Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China
· Delayed Price · Currency is CNY 12.99
+0.34 (2.69%)
At close: Mar 27, 2025, 2:57 PM CST
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 29.60 billion as of April 3, 2025. Its market cap has increased by 40.61% in one year.
Market Cap
29.60B
Enterprise Value
30.88B
Revenue
5.70B
Ranking
n/a
PE Ratio
21.87
Stock Price
12.99
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has increased from 22.34B to 29.60B, an increase of 32.50%. That is a compound annual growth rate of 13.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2025 | 29.22B | 10.62% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 323.33B |
| Shenzhen Mindray Bio-Medical Electronics | 277.99B |
| WuXi AppTec | 189.97B |
| Aier Eye Hospital Group | 123.28B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.56B |
| Shanghai United Imaging Healthcare | 101.95B |
| Yunnan Baiyao Group Co.,Ltd | 101.36B |
| Sichuan Biokin Pharmaceutical | 99.04B |